164 related articles for article (PubMed ID: 21861084)
1. Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®).
Pardo-López D; Francés-Muñoz E; Gallego-Pinazo R; Díaz-Llopis M
Graefes Arch Clin Exp Ophthalmol; 2012 Nov; 250(11):1703-4. PubMed ID: 21861084
[No Abstract] [Full Text] [Related]
2. Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema.
Turaka K; Kwong HM; De Souza S
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):196-7. PubMed ID: 23402344
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.
Khurana RN; Appa SN; McCannel CA; Elman MJ; Wittenberg SE; Parks DJ; Ahmad S; Yeh S
Ophthalmology; 2014 Jan; 121(1):67-71. PubMed ID: 23890421
[TBL] [Abstract][Full Text] [Related]
4. Late migration of dexamethasone implant into anterior chamber.
Cronin KM; Govind K; Kurup SK
Arch Ophthalmol; 2012 Jun; 130(6):711. PubMed ID: 22801828
[No Abstract] [Full Text] [Related]
5. [Dislocation in anterior chamber of dexamethasone intravitreal device].
Cousin M; Hoffart L; Baeteman C; Matonti F
Can J Ophthalmol; 2013 Aug; 48(4):e62-3. PubMed ID: 23931482
[No Abstract] [Full Text] [Related]
6. Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex).
Ong J; Davidoss NH; Bhosale A; Balaratnasingam C
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148568
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
[TBL] [Abstract][Full Text] [Related]
8. Re: Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Yolcu Ü; Tas A; Ilhan A; Altun S; Gundogan FC
Retina; 2015 Mar; 35(3):e24-5. PubMed ID: 25699509
[No Abstract] [Full Text] [Related]
9. Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient.
Stepanov A; Codenotti M; Ramoni A; Prati M; Jiraskova N; Rozsival P; Bandello F
Eur J Ophthalmol; 2016 Apr; 26(3):e52-4. PubMed ID: 26615950
[TBL] [Abstract][Full Text] [Related]
10. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).
Kang H; Lee MW; Byeon SH; Koh HJ; Lee SC; Kim M
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1819-1825. PubMed ID: 28601910
[TBL] [Abstract][Full Text] [Related]
11. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
12. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.
Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E
J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187
[TBL] [Abstract][Full Text] [Related]
13. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
[TBL] [Abstract][Full Text] [Related]
14. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
Bakri SJ; Omar AF
J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration.
Röck D; Bartz-Schmidt KU; Röck T
BMC Ophthalmol; 2019 May; 19(1):120. PubMed ID: 31138164
[TBL] [Abstract][Full Text] [Related]
16. Repositioning of dexamethasone intravitreal implant (Ozurdex) migrated into the anterior chamber.
Vela JI; Crespí J; Andreu D
Int Ophthalmol; 2012 Dec; 32(6):583-4. PubMed ID: 22763812
[TBL] [Abstract][Full Text] [Related]
17. Surgical Management of Anterior Chamber Migration of a Dexamethasone Intravitreal Implant.
Stelton CR; Townsend J; Peterson LT; Khurana RN; Yeh S
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(7):756-9. PubMed ID: 26247457
[TBL] [Abstract][Full Text] [Related]
18. Anterior Chamber Migration of Ozurdex Implants.
Kayıkcıoğlu Ö; Doğruya S; Sarıgül C; Mayalı H; Kurt E
Turk J Ophthalmol; 2020 Apr; 50(2):115-122. PubMed ID: 32367704
[TBL] [Abstract][Full Text] [Related]
19. RETINA.
Retina; 2018 Jun; 38 Suppl 3():1-13. PubMed ID: 29889714
[No Abstract] [Full Text] [Related]
20. Dislocation of dexamethasone intravitreous implant.
Voykov B; Bartz-Schmidt KU
Arch Ophthalmol; 2012 Jun; 130(6):706. PubMed ID: 22801827
[No Abstract] [Full Text] [Related]
[Next] [New Search]
